Discordance between non-HDL-cholesterol and LDL-particle measurements: Results from the Multi-Ethnic Study of Atherosclerosis

Atherosclerosis

Volumn 229, Issue 2, 2013, Pages 517-523

  deGoma, Emil M ^a   Davis, Mat D ^a   Dunbar, Richard L ^a   Mohler, Emile R ^a   Greenland, Philip ^b   French, Benjamin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Apolipoprotein B; Cholesterol; LDL particle number; Lipoproteins; Risk assessment

Indexed keywords

CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; COMORBIDITY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HISPANIC; HORMONE SUBSTITUTION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

APOLIPOPROTEIN B; CHOLESTEROL; LDL-PARTICLE NUMBER; LIPOPROTEINS; RISK ASSESSMENT;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEINS B; ASIAN AMERICANS; ATHEROSCLEROSIS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 84880610089     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.03.012     Document Type: Article

References (32)

1. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285:2486-2497.
2. Barter P.J., Ballantyne C.M., Carmena R., et al. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. JIntern Med 2006, 259:247-258.
3. Genest J., McPherson R., Frohlich J., et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations. Can J Cardiol 2009, 25:567-579.
4. Brunzell J.D., Davidson M., Furberg C.D., et al. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. JAm Coll Cardiol 2008, 51:1512-1524.
5. Davidson MH, Ballantyne CM, Jacobson TA, etal. Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists. J Clin Lipidol;5:338-67.
6. Greenland P., Alpert J.S., Beller G.A., et al. ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010, 122:e584-636.
7. Ramjee V, Sperling LS and Jacobson TA, Non-high-density lipoprotein cholesterol versus apolipoprotein B in cardiovascular risk stratification do the math. J Am Coll Cardiol;58:457-63.
8. Sniderman A.D., Williams K., McQueen M.J., Furberg C.D. When is equal not equal?. JClin Lipidol 2010, 4:83-88.
9. Jeyarajah E.J., Cromwell W.C., Otvos J.D. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 2006, 26:847-870.
10. Mora S., Szklo M., Otvos J.D., et al. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007, 192:211-217.
11. DeGoma E.M., French B., Dunbar R.L., Allison M.A., Mohler E.R., Budoff M.J. Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2012, 224:274-279.
12. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
13. Folsom A.R., Kronmal R.A., Detrano R.C., et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2008, 168:1333-1339.
14. Stein J.H., Korcarz C.E., Hurst R.T., et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. JAm Soc Echocardiogr: Off Pub Am Soc Echocardiogr 2008, 21:93-111. quiz 189-190.
15. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National cholesterol Education Program adult treatment panel III guidelines. Circulation 2004, 110:227-239.
16. Cromwell W.C., Barringer T.A. Low-density lipoprotein and apolipoprotein B: clinical use in patients with coronary heart disease. Curr Cardiol Rep 2009, 11:468-475.
17. Cromwell W.C., Otvos J.D. Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl. Am J Cardiol 2006, 98:1599-1602.
18. Mudd J.O., Borlaug B.A., Johnston P.V., et al. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease. JAm Coll Cardiol 2007, 50:1735-1741.
19. Haffner S.M., D'Agostino R., Goff D., et al. LDL size in African Americans, Hispanics, and non-Hispanic whites: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol 1999, 19:2234-2240.
20. Cromwell W.C., Otvos J.D., Keyes M.J., et al. LDL particle number and risk of future cardiovascular disease in the framingham offspring study-implications for LDL management. JClin Lipidol 2007, 1:583-592.
21. Otvos JD, Mora S, Shalaurova I, Greenland P, Mackey RH and Goff DC Jr. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. J Clin Lipidol;5:105-113.
22. Otvos J.D., Mora S., Shalaurova I., Greenland P., Mackey R.H., Goff D.C. Discordance between LDL cholesterol and LDL particle number as assessed in the Multi-Ethnic Study of Atherosclerosis (MESA), MESA Manuscript MC120 2010.
23. El Harchaoui K., van der Steeg W.A., Stroes E.S., et al. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. JAm Coll Cardiol 2007, 49:547-553.
24. McQueen M.J., Hawken S., Wang X., et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008, 372:224-233.
25. Pischon T., Girman C.J., Sacks F.M., Rifai N., Stampfer M.J., Rimm E.B. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005, 112:3375-3383.
26. Benn M., Nordestgaard B.G., Jensen G.B., Tybjaerg-Hansen A. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study. Arterioscler Thromb Vasc Biol 2007, 27:661-670.
27. Mora S., Otvos J.D., Rifai N., Rosenson R.S., Buring J.E., Ridker P.M. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 2009, 119:931-939.
28. Virani SS, Catellier DJ, Pompeii LA, etal. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Atherosclerosis;219:596-602.
29. Kathiresan S., Otvos J.D., Sullivan L.M., et al. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation 2006, 113:20-29.
30. Sniderman A.D., St-Pierre A.C., Cantin B., Dagenais G.R., Despres J.P., Lamarche B. Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk. Am J Cardiol 2003, 91:1173-1177.
31. Sniderman A.D., Hogue J.C., Bergeron J., Gagne C., Couture P. Non-HDL cholesterol and apoB in dyslipidaemia. Clin Sci (Lond) 2008, 114:149-155.
32. Tsao C.W., Preis S.R., Peloso G.M., et al. Relations of long-term and contemporary lipid levels and lipid genetic risk scores with coronary artery calcium in the Framingham Heart Study. JAm Coll Cardiol 2012, 60:2364-2371.